abstract |
The present invention relates to one or more ligands of a potassium channel β subunit for use in therapy, and in particular for use in treating or preventing a sleep disorder in a subject. The invention also provides a method of screening a test compound to determine if it is a substrate of a potassium channel β subunit. |